European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership

Ofori-Adjei, D.; Matee, M.I.; Manyando, C.; Ndumbe, P.M.; Corrah, T.; Jaoko, W.G.; Kitua, A.Y.; Ambene, H.P.; Ndounga, M.; Zijenah, L.; Agwale, S.; Shongwe, S.; Nyirenda, T.; Makanga, M.

European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership

Date

2009

Authors

Ofori-Adjei, D.

Matee, M.I.

Manyando, C.

Ndumbe, P.M.

Corrah, T.

Jaoko, W.G.

Kitua, A.Y.

Ambene, H.P.

Ndounga, M.

Zijenah, L.

Publisher

BMC Public Health 20(9): 249

Abstract

European and Developing Countries Clinical Trials Partnership (EDCTP) was founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union (EU) member states, Norway, Switzerland, and Developing Countries, formed to fund acceleration of new clinical trial interventions to fight the human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), malaria and tuberculosis (TB) in the sub-Saharan African region. EDCTP seeks to be synergistic with other funding bodies supporting research on these diseases.